Week of January 18th 2022 | Vol. 11, Issue 3
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY

October 2022- Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
Pine Tree Equity IV, LP ("Pine Tree Equity"), a private equity firm based in Miami, FL, is pleased to announce that it has recapitalized Summit Health Pharmacy, LLC ("Summit" or the "Company") in December 2021. The Company, founded in 1995 and headquartered in Brookhaven, PA, is a leading provider of pharmacy compounding services, with a focus on rare pediatric metabolic medications.
Revenue cycle management company R1 RCM on Monday announced it plans to acquire Cloudmed in an all-stock transaction that values the software company at roughly $4.1 billion. The deal was announced in a press release as the industry meets virtually for the J.P. Morgan Healthcare Conference.
Digital health had another standout year in 2021, with startups raising an eye-popping $29.1 billion across 729 deals, according to Rock Health, a venture fund dedicated to digital health. Overall, investment in the market nearly doubled 2020’s $14.9 billion former record haul, the company noted in its year-end funding report.
After launching from stealth last March, Transcarent has landed $200 million in series C funding to power its premium-free approach to employer-sponsored healthcare. The infusion of capital bumps the company’s valuation to $1.62 billion, boosting Transcarent to the ranks of digital health unicorns, the startup confirmed to Fierce Healthcare.

The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.

Check out Tanner’s feature in the 2022 CTS Handbook highlighting the company’s capabilities in solving the most complex sourcing and supply challenges.